These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 14661403)

  • 21. ADHD and the rise in stimulant use among children.
    Mayes R; Bagwell C; Erkulwater J
    Harv Rev Psychiatry; 2008; 16(3):151-66. PubMed ID: 18569037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexmethylphenidate for attention deficit hyperactivity disorder.
    Coury D
    Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motor skills of children newly diagnosed with Attention Deficit Hyperactivity Disorder prior to and following treatment with stimulant medication.
    Brossard-Racine M; Shevell M; Snider L; Bélanger SA; Majnemer A
    Res Dev Disabil; 2012; 33(6):2080-7. PubMed ID: 22796639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
    Jensen PS
    Am J Manag Care; 2009 May; 15(5 Suppl):S129-40. PubMed ID: 19601688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 26. [How to treat ADHD/DAMP? Is there a conclusive answer? A critical survey of the MTA trial?].
    Hansen L; Thomsen PH
    Ugeskr Laeger; 2005 Nov; 167(48):4555-9. PubMed ID: 16324436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
    Hodgkins P; Sasané R; Meijer WM
    Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
    [No Abstract]   [Full Text] [Related]  

  • 30. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
    Harpin VA
    Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the ability of children with attention deficit hyperactivity disorder to accurately report the effects of medication on their behavior.
    Ardoin SP; Martens BK
    J Appl Behav Anal; 2000; 33(4):593-610. PubMed ID: 11214033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of stimulants on electrodermal studies in Fragile X syndrome.
    Hagerman RJ; Miller LJ; McGrath-Clarke J; Riley K; Goldson E; Harris SW; Simon J; Church K; Bonnell J; Ognibene TC; McIntosh DN
    Microsc Res Tech; 2002 May; 57(3):168-73. PubMed ID: 12112453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of studies of drug treatment efficacy for attention deficit disorder with hyperactivity in adolescents.
    Varley CK
    Psychopharmacol Bull; 1985; 21(2):216-21. PubMed ID: 2860692
    [No Abstract]   [Full Text] [Related]  

  • 35. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bulimia nervosa and attention deficit hyperactivity disorder: a possible role for stimulant medication.
    Dukarm CP
    J Womens Health (Larchmt); 2005 May; 14(4):345-50. PubMed ID: 15916509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention-deficit/hyperactivity disorder: management.
    Szymanski ML; Zolotor A
    Am Fam Physician; 2001 Oct; 64(8):1355-62. PubMed ID: 11681777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
    Calver J; Sanfilippo F; Preen D; Bulsara M
    Aust N Z J Public Health; 2007 Dec; 31(6):533-9. PubMed ID: 18081573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.